Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
4.720
+0.285 (6.43%)
At close: Aug 13, 2025, 4:00 PM
4.630
-0.090 (-1.91%)
Pre-market: Aug 14, 2025, 8:56 AM EDT
Acurx Pharmaceuticals Stock Forecast
ACXP's stock price has decreased by -87.38% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Acurx Pharmaceuticals stock ranges from a low of $31 to a high of $240. The average analyst price target of $143.67 forecasts a 2,943.86% increase in the stock price over the next year.
Price Target: $143.67 (+2,943.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Acurx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $31 | Strong Buy | Maintains | $8 → $31 | +556.78% | Aug 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $160 | Strong Buy | Initiates | $160 | +3,289.83% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +4,984.75% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +4,984.75% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +4,984.75% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
4.59M
Revenue Next Year
132.60K
from 4.59M
Decreased by -97.11%
EPS This Year
-0.51
from -17.45
EPS Next Year
-0.52
from -0.51
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.2M | 409,500 | 14.2M | ||
| Avg | 4.6M | 132,600 | 4.6M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | -91.1% | 10,590.0% | ||
| Avg | - | -97.1% | 3,361.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.47 | -0.41 | -0.37 |
| Avg | -0.51 | -0.52 | -0.53 |
| Low | -0.59 | -0.58 | -0.61 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.